DR Horton Net Worth
DR Horton Net Worth Breakdown | DHI |
DR Horton Net Worth Analysis
DR Horton's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including DR Horton's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of DR Horton's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform DR Horton's net worth analysis. One common approach is to calculate DR Horton's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares DR Horton's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing DR Horton's net worth. This approach calculates the present value of DR Horton's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of DR Horton's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate DR Horton's net worth. This involves comparing DR Horton's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into DR Horton's net worth relative to its peers.
Enterprise Value |
|
To determine if DR Horton is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding DR Horton's net worth research are outlined below:
| DR Horton generated a negative expected return over the last 90 days | |
| Over 83.0% of the company shares are held by institutions such as insurance companies | |
| On 19th of November 2024 DR Horton paid $ 0.4 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Disposition of 5650 shares by Barbara Allen of DR Horton at 163.1 subject to Rule 16b-3 |
DR Horton Quarterly Good Will |
|
DR Horton uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in DR Horton. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DR Horton's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 18th of April 2024 Upcoming Quarterly Report | View | |
| 18th of July 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 5th of November 2024 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Know DR Horton's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DR Horton is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DR Horton backward and forwards among themselves. DR Horton's institutional investor refers to the entity that pools money to purchase DR Horton's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Norges Bank | 2024-06-30 | 3.8 M | Greenhaven Associates Inc | 2024-09-30 | 3.7 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 3.4 M | Northern Trust Corp | 2024-09-30 | 2.9 M | Legal & General Group Plc | 2024-06-30 | 2.6 M | Smead Capital Management Inc | 2024-09-30 | 2.5 M | Arrowstreet Capital Limited Partnership | 2024-06-30 | 2.5 M | Amvescap Plc. | 2024-06-30 | 2.5 M | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2024-06-30 | 2.4 M | Vanguard Group Inc | 2024-09-30 | 34.4 M | Blackrock Inc | 2024-06-30 | 34.1 M |
Follow DR Horton's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 51.98 B.Market Cap |
|
Project DR Horton's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.13 | 0.10 | |
| Return On Capital Employed | 0.21 | 0.52 | |
| Return On Assets | 0.13 | 0.10 | |
| Return On Equity | 0.19 | 0.35 |
When accessing DR Horton's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures DR Horton's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of DR Horton's profitability and make more informed investment decisions.
Evaluate DR Horton's management efficiency
DR Horton has Return on Asset of 0.1113 % which means that on every $100 spent on assets, it made $0.1113 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1963 %, implying that it generated $0.1963 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.35, while Return On Tangible Assets are projected to decrease to 0.1. As of now, DR Horton's Total Current Assets are increasing as compared to previous years. The DR Horton's current Other Assets is estimated to increase to about 6.3 B, while Non Currrent Assets Other are forecasted to increase to (159.1 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 78.37 | 0.03 | |
| Tangible Book Value Per Share | 77.88 | 0.03 | |
| Enterprise Value Over EBITDA | 10.08 | 54.10 | |
| Price Book Value Ratio | 2.48 | 46.36 | |
| Enterprise Value Multiple | 10.08 | 54.10 | |
| Price Fair Value | 2.48 | 46.36 | |
| Enterprise Value | 706 M | 670.7 M |
Examining the leadership quality of DR Horton offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 1.4631 | Revenue 36.8 B | Quarterly Revenue Growth (0.05) | Revenue Per Share 111.689 | Return On Equity 0.1963 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DR Horton insiders, such as employees or executives, is commonly permitted as long as it does not rely on DR Horton's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DR Horton insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DR Horton Corporate Filings
F4 | 21st of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 19th of November 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 30th of October 2024 Other Reports | ViewVerify | |
8K | 29th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
DR Horton Earnings per Share Projection vs Actual
DR Horton Corporate Directors
| Michael Buchanan | Independent Director | Profile | |
| Michael Hewatt | Independent Director | Profile | |
| Barbara Allen | Independent Director | Profile | |
| Bradley Anderson | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 1.2 | Earnings Share 14.34 | Revenue Per Share 111.689 | Quarterly Revenue Growth (0.05) |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.